Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?

J Thorac Oncol. 2018 Jun;13(6):e102-e103. doi: 10.1016/j.jtho.2018.01.027.

¹ Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
² Divison of Immunology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
³ Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa; Department of Thoracic Oncology, King Hussein Cancer Center, Amman, Jordan.
⁴ Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa. Electronic address: jun-zhang-1@uiowa.edu.

No abstract available

Publication types